Topiramate reduces the harm of excessive drinking: implications for public health and primary care
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Aims Having demonstrated previously the efficacy of topiramate—a sulfamate‐substituted fructopyranose derivative—as pharmacotherapy for treating alcohol dependence, promoting abstinence and reducing the harmful psychosocial consequences of drinking, we investigated whether topiramate also promoted ‘safe’ levels of drinking: ≤ 1 and ≤ 2 standard drinks/day for women and men, respectively, among alcohol‐dependent individuals. Design, setting and participants In a double‐blind, randomized, controlled, 12‐week clinical trial conducted in San Antonio, Texas, 75 alcohol‐dependent adults received topiramate and 75 received placebo as an adjunct to weekly standardized medication compliance management. Measurements For this secondary analysis of data from that trial, we calculated, based on self‐reports, specific intervals of up to 30 days of continuous ‘safe’ drinking for each subject. Findings The average longest ‘safe’ drinking period was 16.7 days for topiramate recipients versus 8.9 days for placebo recipients. By day 50 of treatment, 44% versus 26.4% had achieved ≥ 7 and 30.8% versus 10% had achieved ≥ 14 continuous ‘safe’ drinking days. Similarly, topiramate increased the relative likelihood of continuous ‘safe’ drinking from 77% for ≥ 7 days [relative risk (RR) for achieving continuous ‘safe’ drinking = 1.77] to threefold for ≥ 14 days (RR = 3.37) and fourfold for ≥ 28 days (RR = 4.07). Thus, participants who received topiramate were more likely to achieve longer periods of ‘safe’ drinking compared with those who received placebo. Conclusions For alcohol‐dependent individuals who drank within an abstinence‐oriented treatment program, topiramate promoted ‘safe’ drinking. Topiramate’s potential to decrease the public health consequences of hazardous drinking needs to be established in future long‐term studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oral topiramate for treatment of alcohol dependence: A randomised controlled trial
Johnson, B. A., Ait-Daoud, N., Bowden, C. L., DiClemente, C. C., Roache, J. D., Lawson, K., Javors, M. A., & Ma, J. Z. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13370-3 · Cited by 743
Self-citationRecovery from DSM‐IV alcohol dependence: United States, 2001–2002
Dawson, D. A., Grant, B. F., Stinson, F. S., Chou, P. S., Huang, B., & Ruan, W. J. (2005) · Addiction · doi:10.1111/j.1360-0443.2004.00964.x · Cited by 597
Harm reduction approaches to alcohol use
Marlatt, G. A., & Witkiewitz, K. (2002) · Addictive Behaviors · doi:10.1016/s0306-4603(02)00294-0 · Cited by 491
Mode-specific effects among three treatments for depression.
Imber, S. D., Pilkonis, P. A., Sotsky, S. M., & Elkin, I. (1990) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.58.3.352 · Cited by 330
Cited by
Goodman, A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.030 · Cited by 413
Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings
Johnson, B. A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.005 · Cited by 264
Self-citationComparing topiramate with naltrexone in the treatment of alcohol dependence
Baltieri, D. A., Daró, F. R., Ribeiro, P. L., & De Andrade, A. G. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02355.x · Cited by 145
What Works in Substance Abuse Treatment Programs for Offenders?
Bahr, S. J., Masters, A. L., & Taylor, B. M. (2012) · The Prison Journal · doi:10.1177/0032885512438836 · Cited by 107
Packages of care for alcohol use disorders in low- and middle-income countries
Benegal, V., Chand, P. K., & Obot, I. S. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000170 · Cited by 94
“Topiramate (glutamate antagonist Two RCTs [67,68] RCT comparing disulfiram and topiramate in patients with alcohol dependence in India [69]”
Background
Metadata
- Authors
- Ma, J. Z., Ait‐Daoud, N., & Johnson, B. A.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2006-10-10
- Volume
- 101
- Issue
- 11
- Pages
- 1561-1568
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W2019008364
- Cited by
- 36
- References
- 4
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Topiramate reduces the harm of excessive drinking: implications for public health and primary care. https://app.cochat.ai/papers/10.1111/j.1360-0443.2006.01576.x
- The paper
- Ma, J. Z., Ait‐Daoud, N., & Johnson, B. A. (2006). Topiramate reduces the harm of excessive drinking: implications for public health and primary care. Addiction. https://doi.org/10.1111/j.1360-0443.2006.01576.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.